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DOI 10.1016/j.ccr.2011.04.019SUMMARYSmall cell lung cancer (SCLC) is one of the most lethal human malignancies. To investigate the cellular
origin(s) of this cancer, we assessed the effect of Trp53 and Rb1 inactivation in distinct cell types in the adult
lung using adenoviral vectors that target Cre recombinase to Clara, neuroendocrine (NE), and alveolar type 2
(SPC-expressing) cells. Using these cell type-restricted Adeno-Cre viruses, we show that loss of Trp53 and
Rb1 can efficiently transform NE and SPC-expressing cells leading to SCLC, albeit SPC-expressing cells at
a lesser efficiency. In contrast, Clara cells were largely resistant to transformation. The results indicate that
although NE cells serve as the predominant cell of origin of SCLC a subset of SPC-expressing cells are also
endowed with this ability.INTRODUCTION
Small cell lung cancer (SCLC) is a devastating disease and is,
along with non-small cell lung cancer (NSCLC), the most
common cause of cancer related mortality worldwide (Jemal
et al., 2008). Uncovering the identity of the cell type(s) that
give rise to both lung cancer subtypes would constitute an
important advancement for the field. Tissue stem cells are
attractive candidates for the cells of origin of tumors, as their
long in vivo life span would allow them to accumulate genetic
mutations that drive tumorigenesis (Smalley and Ashworth,
2003). It is possible that committed progenitors and differenti-
ated cells can also serve as the primary target, although this
may depend upon their turnover rate and the acquisition of
specific and/or combinations of genetic modifications that
confer self-renewal capacity. Identifying the cell(s) of origin
and elucidating the genetic and molecular changes associated
with their transformation are of critical importance and will
help to focus intervention strategies on eliminating the cancerSignificance
The identification of the cell type(s) fromwhich SCLC originates
and treatment. In this paper, we validate the use of cell type-res
distinct cell populations in the adult mouse lung. In doing so,
SCLC. Our study provides additional tools to address questions
importance of specifically targeting NE cells for the treatment
754 Cancer Cell 19, 754–764, June 14, 2011 ª2011 Elsevier Inc.propagating cells that most likely retain many of the character-
istics of its cell of origin.
Understanding the normal cellular hierarchy within the lung is
an important prerequisite to identify the cells of origin of cancer.
To date, most of our understanding of the relationship between
cell types and the existence of stem/progenitor cells in the
lung originates from studies of mouse models. The adult mouse
lung can be compartmentalized along the proximal-distal axis
into three structurally distinct domains: the first compartment
is composed of trachea and extrapulmonary bronchi, the second
compartment includes intrapulmonary bronchi, bronchioles, and
terminal bronchioles, and the third compartment is the alveolar
ducts or gas-exchanging airspaces (for review, see Rock et al.,
2010). The epithelium of the mouse trachea contains an abun-
dant population of basal cells as well as ciliated epithelial lining
cells, goblet cells, and some Clara cells. Solitary neuroendocrine
(NE) cells are also present but are far more rare. In the trachea,
Keratin 5 positive (Krt5+) basal cells have been shown to act as
stem/progenitor cells, with the ability to self-renew and giveis critical in the development of methods for early diagnosis
tricted Adeno-Cre vectors in directing Trp53 andRb1 loss to
we show that NE cells are the predominant cells of origin of
related to the cell of origin of lung cancer, and highlights the
of SCLC.
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et al., 2009). In the more distal airways, Clara cells are abundant
and line the small bronchi and bronchioles. In this region of the
lung Clara cells can both self-renew and generate ciliated cells
under both homeostatic conditions and in response to epithelial
injury (Rawlins et al., 2009b). In the intrapulmonary airways, a
limited number of pulmonary NE cells are present, the majority
of which can be found in clusters commonly referred to as neuro-
epithelial bodies (NEBs). The latter seem to have a higher preva-
lence near airway junctions in the bronchioles. The most distal
region of the lung is organized into a complex system of alveoli,
composed of alveolar type 1 (AT1) cells and cuboidal alveolar
type 2 (AT2) cells. In the alveoli, AT2 cells are considered to be
the major stem/progenitor cell of the alveolar epithelium based
upon their ability to self-renew and give rise to AT1 cells (Adam-
son and Bowden, 1974; Evans et al., 1975). The transition
between the terminal bronchioles and the alveoli is known as
the bronchioalveolar duct junction (BADJ) (Giangreco et al.,
2002).
The specific cell type(s) that upon genetic alteration gives rise
to SCLC is not yet known. This is largely due to the advanced
stage of disease in most patients at the time of diagnosis
(Jackman and Johnson, 2005). Interestingly, lung tumor sub-
types generally follow a proximal-to-distal distribution pattern,
moving distally from the trachea: squamous cell carcinoma
(SCC), SCLC, and adenocarcinoma/bronchioalveolar carci-
noma (for review, see Giangreco et al., 2007). It is therefore
speculated that different tumor subclasses arise from cells of
origin located within a defined regional compartment/microen-
vironment. For example, human and mouse SCLC predomi-
nately localize to the midlevel bronchioles, and express markers
of NE cells, while markers defining other cells types are not ex-
pressed (Wistuba et al., 2001). However, whether SCLC arises
from differentiated NE cells or from stem/progenitor cells has
not been established. It is also unclear whether SCLC and
NSCLC originate from different cells. The observation that
SCLC can exhibit epidermoid carcinoma, adenocarcinoma,
and/or large cells carcinoma-like features, would argue for the
existence of a ‘‘common’’ cell of origin for these lung cancers
(Travis, 2002).
Analysis of the underlying genetic alterations of lung cancer
has revealed an association between the histopathology of the
disease and the observed genetic lesions (Sekido et al., 2003).
For example, in the lung loss of Rb1 function has been shown
to negatively regulate NE cell differentiation, and thismay explain
why Rb1 loss is predominately associated with SCLC. Con-
versely, activating mutations in K-ras are almost exclusively
found in NSCLC, while Trp53 loss-of-function is observed in
both SCLC and NSCLC (for review, see Meuwissen and Berns,
2005). Although distinct lesions are clearly associated with
specific tumor cell types, it remains unclear to what extent the
cell of origin is a determining factor in the tumor phenotype.
Mouse models are well suited to sample distinct cell populations
for their propensity to give rise to specific tumors (for review, see
Visvader, 2011). This has been nicely demonstrated in pancre-
atic cancer models using cell type-specific Cre expression
(Gidekel Friedlander et al., 2009; Wang et al., 2009). Here, we
have addressed this question in lung focusing on the likely cell
of origin of SCLC.RESULTS
Restricting Cre-Recombination to Specific Lung
Epithelial Cells using Recombinant Adenoviral Vectors
To target specific cell types, we chose to use the Cre-loxP
system, which is an effective method for expressing or deleting
a target gene in Cre-expressing cells. We generated a series of
recombinant adenoviruses expressing Cre recombinase from
specific lung epithelial gene promoters. We chose to target Clara
cells, AT2 cells, and NE cells. These cell types, based on
previous studies, might prove the most likely candidates either
on the basis of markers that are shared between tumors and
normal cells, or on the basis of studies that illustrated the regen-
erative capacity of distinct cell types after lung injury.
In order to target Clara cells, we utilized a DNA fragment that
contains 2.1 kb of upstream 50 flanking sequences of the mouse
CC10 gene (Ray et al., 1993). CC10 is expressed in tracheal Clara
cells, bronchiolar Clara cells, including bronchioalveolar stem
cells (BASCs) (Kim et al., 2005) and was more recently shown
to be expressed, albeit to a low level in a rare cell population in
the alveoli, that also expresses SPC (Rawlins et al., 2009b). Alve-
olar type 2 (AT2) cells were targeted using the Surfactant Protein
C (SPC) gene promoter. Surfactant protein C is expressed in AT2
cells present in the alveoli and in BASCs. We utilized a murine
DNA fragment that extends 4.8 kb upstreamof the transcriptional
start site of the SPC gene (Glasser et al., 2005). This promoter
construct shows sequence homology to the 3.7 kb human SPC
promoter fragment that has been used in the generation of
a transgenic mouse (SPC-rtTA) (Perl et al., 2002b). The neural/
neuroendocrine specific calcitonin/calcitonin-gene related
peptide (CGRP) promoter (Johnston et al., 1998) was used to
target pulmonary NE cells. This promoter has been shown in
a number of studies to limit transgene expression to neuroendo-
crine and neural cells (Baetscher et al., 1991). Using these
adenoviral vectors (Ad5-CC10-Cre, Ad5-SPC-Cre, and Ad5-
CGRP-Cre), we can delete one or more tumor suppressor genes
in a cell type-restricted manner in the adult mouse lung.
To validate the specificity of adenovirus promoter targeting,
we made use of the Rosa26R-LacZ andmT/mG reporter mouse
strains (Muzumdar et al., 2007; Soriano, 1999). In order to target
pulmonary epithelial cells, high titer recombinant adenoviral
vectors were administered intratracheally and targeted cells
were identified by immunohistochemical staining, cellular loca-
tion andmorphology. Histochemical staining for b-galactosidase
activity in lung tissue sections obtained from Rosa26R-LacZ
mice 2–3 weeks following Ad5-CC10-Cre infection showed
a restricted pattern of LacZ+ cells (Figure 1A). Beta-galactosi-
dase activity was exclusively observed in cells lining the lobar
conducting airways, bronchioles and terminal bronchioles (Fig-
ure 1A). Immunostaining with an anti-CC10 antibody on consec-
utive sections revealed that the LacZ+ cells were indeed Clara
cells (Figure 1B). No LacZ+ cells were observed in the alveoli,
and consistent with this observation, no colocalization was
observed upon immunostaining for pro-SPC, a marker for type
2 cells (Figure 1C). An identical recombination pattern was also
observed in Ad5-CC10-Cre-infected mT/mG animals, where
multilabel confocal colocalization studies confirmed the highly
predominant infection of CC10-positive Clara cells (data not
shown). ‘‘Clara-like’’ cells surrounding the NEBs were also foundCancer Cell 19, 754–764, June 14, 2011 ª2011 Elsevier Inc. 755
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Figure 1. Rosa26R-LacZMice Show a Distinct Pattern of Reporter Gene Expression following Intratracheal Injection of Cell Type-Restricted
Ad5-Cre Viruses
(A–C) Adult lung sections of Rosa26R-LacZ mice infected with Ad5-CC10-Cre virus (titer = 1.5 3 109). (A) LacZ+ cells observed in the lining of the lobar
bronchus, bronchiole, and terminal bronchiole (inset). No LacZ+ cells were observed in the alveoli. (B) Colocalization of LacZ+ cells with anti-CC10, Clara cells.
(C) No colocalization of LacZ+ cells with anti-pro-SPC, alveolar type 2 cells.
(D–F) Adult lung sections of Rosa26R-LacZ mice infected with Ad5-SPC-Cre virus (titer = 2.5 3 109). (D) Switching was observed in type 2 cells resident in the
alveoli, whereas no switching was observed in cells lining the bronchioles/terminal bronchioles. (E) Clara cells are strongly stained by anti-CC10; however, no
colocalization was observed with LacZ+ cells. (F) A number of LacZ+ AT2 cells are colocalized with anti-pro-SPC.
(G–I) Adult lung sections of Rosa26R-LacZ animals infected with Ad5-CGRP-Cre virus (titer = 1.5 3 109). (G) Two distinct LacZ+ cells were observed lining the
bronchioles. Arrows indicate putative CGRP+ NE cells. (H) No colocalization of LacZ+ cells was observed with Clara cells following anti-CC10 staining. (I) No
colocalization of LacZ+ was observed with AT2 cells following anti-pro-SPC staining.
Scale bars in (A)–(I) equal 100 mm; inserts equal 20 mm.
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Cell of Origin of Small Cell Lung Cancerto be switched following Ad5-CC10-Cre infection of mT/mG
reporter animals, however no colocalization was observed
following immunofluorescence staining with an anti-synapto-
physin (Syn) antibody, a marker of NE cells (Figure 2A). In scan-
ning a large number of cryosections, we found only a single NE
cell that showed Cre-mediated switching after infection with
Ad5-CC10-Cre virus.
Conversely, administration of Ad5-SPC-Cre virus yielded
b-galactosidase activity in alveolar pneumocytes resident within
the parenchyma (Figure 1D). Very infrequently, a LacZ+ cell was
observed in close proximity to the BADJ, in a continuum with the
bronchiole lining (data not shown). However, as we did not
detect colocalization following anti-CC10 staining we cannot
confirm whether these switched cells are indeed BASCs.756 Cancer Cell 19, 754–764, June 14, 2011 ª2011 Elsevier Inc.Overall we did not observe colocalization of LacZ+ cells residing
within the parenchyma with anti-CC10 (Figure 1E). Ad5-SPC-
Cre-switched cells did, however, colocalize with AT2 cells, as
determined by costaining with an anti-pro-SPC antibody (Fig-
ure 1F). Moreover, examination of around 150–200 NEBs in
mT/mG sections obtained from Ad5-SPC-Cre-infected mice, re-
vealed no colocalization of GFP+ switched with Syn+ NEBs (data
not shown) whereas such staining was easily detected when
Ad5-CGRP-Cre virus was used.
Pulmonary NE cells represent an extremely rare cell popula-
tion in the adult mouse lung and are scattered throughout the
epithelium of conducting airways, predominantly as small clus-
ters of cells termed neuroepithelial bodies (NEBs). In line with
the low abundance of pulmonary NE cells in the adult lung,
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A Figure 2. Neuroendocrine Cells Are Selec-
tively Targeted by Cell Type-Restricted
Ad5-Cre Viruses
(A) Adult lung cryosections of mT/mG reporter
mice infected with Ad5-CC10-Cre virus (titer =
1.5 3 109). GFP+, recombined cells (green, FITC),
were observed in close proximity to the NEB. No
colocalization of GFP+ cells with Syn+ cells present
within the NEB.
(B) Adult lung cryosections of mT/mG reporter
mice infected with Ad5-CGRP-Cre virus (1.5 3
109). One GFP+, recombined cell (green, FITC) was
observed in the epithelium of the conducting
airway. Colocalization of the GFP+ cell with Syn+
cells present in the NEB.
Scale bars in (A) and (B) equal 10 mm.
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Cell of Origin of Small Cell Lung Cancervery few LacZ+ cells were detected in the epithelium of intrapul-
monary conducting airways in Rosa26R-LacZ animals following
intratracheal injection with Ad5-CGRP-Cre virus (Figure 1G).
Moreover, LacZ+ cells were generally found as apparently single
cells, tightly surrounded (enclosed) by other airway epithelial
cells, likely representing NE cells (Figure 1H). Ad5-CGRP-Cre-
switched cells did not colocalize with AT2 cells, as detected by
costaining with an anti-pro-SPC antibody (Figure 1I). To confirm
that the Ad5-CGRP-Cre-switched cells are in fact NEB cells, we
stained 25 mm-thick cryosections obtained from mT/mG mice
infected with Ad5-CGRP-Cre with anti-Syn and colocalization
with GFP+ cells was determined by confocal microscopy. As
expected GFP+ cells colocalized with Syn+ cells in the airway
epithelium. All of the switched NE cells were found to be present
within a limited number of NEBs, which typically harbored just
one or two GFP+ cells per NEB (Figure 2B), clearly indicating
that the Ad5-CGRP-Cre virus preferentially targets NE cells in
NEBs of the adult mouse lung. However, we also observed
switching of a small fraction of the Clara cells and ciliated cells
indicating that these cells can express Cre after infection with
Ad5-CGRP-Cre. Although Ad5-CGRP-Cre does cause a very
low level switching in these cell types, the virus is by several
orders of magnitude more effective in switching NE cells than
either Ad5-CC10-Cre or Ad5-SPC-Cre adenovirus.
Taken together, these results confirm that Cre-mediated
recombination is confined to a specific cell population as
dictated by the promoter utilized (Table 1), thereby validating
a series of cell type-restricted Ad5-Cre viruses, which can be
used to address the lineage specificity and cell of origin inmurine
lung cancer.Table 1. Relative Frequency of Observed Ad5-Cre-Switched
Cells
Adenovirus
Neuroendocrine
Cells
Clara/Ciliated
Cells
Alveolar
Type 2 Cells
Ad5-CMV-Cre ++++ ++++ ++++
Ad5-CC10-Cre +/-a ++++ -
Ad5-SPC-Cre - +/- ++++
Ad5-CGRP-Creb ++++ +/- -
aOne NE cell present within an NEB was found to be switched.
b Total cells switched with the Ad5-CGRP-Cre virus is >100-fold lower
than with other viruses.Loss of Trp53 and Rb1 in Specific Populations of Airway
Epithelial Cells Results in Different Tumor Pathologies
and Rates of Tumor Onset
The specific cell type(s) that gives rise, upon genetic alteration to
SCLC, is unknown. Togain insight into the cell of originweutilized
a sporadic mousemodel of lung cancer based on the conditional
inactivation of the Trp53 and Rb1 tumor suppressor genes
(Meuwissen et al., 2003). Loss of Trp53 and Rb1 is achieved in
a variety of lung epithelial cell types by intratracheal infection of
Trp53F/F;Rb1F/F animals with Ad5-CMV-Cre virus. Infected
Trp53F/F;Rb1F/F animals develop lung tumors with striking
morphological and immunophenotypical similarities to human
SCLC (Calbo et al., 2011;Meuwissen et al., 2003). To gain insight
into the target cell for transformation in SCLC, we infected
Trp53F/F;Rb1F/F animals with our cell type-restricted Adeno-Cre
viruses: Ad5-CC10-Cre, Ad5-SPC-Cre and Ad5-CGRP-Cre.
Trp53F/F;Rb1F/F animals also carried the Rosa26R-LacZ reporter
allele (Soriano, 1999), allowing us to monitor Cre-mediated
switching of Trp53 and Rb1 in the various cell populations.
Mice were sacrificed when they became moribund. Consistent
with prior observations, the tumors that most frequently arose
in our cohorts were SCLC (Figure 3A and Table 2).
The time for Rosa26R;Trp53F/F;Rb1F/F to succumb from NE
tumors following injection with cell type-restricted Ad5-Cre
viruses is depicted in Figure 3B. In line with previous findings,
the majority of animals injected with Ad5-CMV-Cre virus devel-
oped NE lung tumors with a median latency of 273 days (Fig-
ure 3B; Meuwissen et al., 2003). A similar trend was observed
in animals following Ad5-CGRP-Cre injection, with the majority
of animals developing NE tumors with a median latency of
362 days (Figure 3B). Approximately half of Rosa26R;Trp53F/F;
Rb1F/F animals injected with Ad5-SPC-Cre virus developed NE
lung tumors (Figure 3B). Although the tumor cell characteristics
of the NE tumors observed in Rosa26R;Trp53F/F;Rb1F/F mice in-
fected with either Ad5-CGRP-Cre or Ad5-SPC-Cre virus were
very similar, the time of occurrence of NE tumors inmice infected
with Ad5-SPC-Cre virus was further delayed (454 days). The
latency of neuroendocrine tumors of animals injected with
Ad5-CC10-Cre virus could not be reliably estimated due to the
paucity of tumors that were observed and the predominance
of other causes of death after 18 months.
Recently, a relationship between naphthalene-induced lung
injury and NSCLC has been demonstrated (Kim et al., 2005).Cancer Cell 19, 754–764, June 14, 2011 ª2011 Elsevier Inc. 757
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Figure 3. Loss of Trp53 and Rb1 in Specific Cellular Compartments
Results in Different Tumor Pathologies and Rates of Tumor Onset
(A) Histological spectrum of lesions in Rosa26R;Trp53F/F;Rb1F/F mice infected
with cell type-restricted Ad5-Cre viruses. The bar graph represents the
histopathology spectrum of Rosa26R;Trp53F/F;Rb1F/F animals infected with
cell type-restricted Ad5-Cre viruses.
(B) The incidence of NE lung tumors inmice carrying conditional Trp53 andRb1
alleles following infection with cell type-restricted Ad5-Cre viruses. Curves
showing thepercentageofRosa26R;Trp53F/F;Rb1F/Fmice that died fromanNE
tumor following infection with Ad5-CMV-Cre virus (red curve), Ad5-CGRP-Cre
virus (blue curve; n = 30; median survival age (T50) = 363.5 days; p = 0.0095**),
Ad5-SPC-Cre virus (yellow curve; n = 33; T50 = undefined; p < 0.0001***), and
Ad5-CC10-Cre virus (green curve; n = 30; T50 = undefined; p < 0.0001***).
See Figure S1 for the effect of naphthalene-induced damage on small-cell
tumor initiation in Trp53F/F;Rb1F/F compound mice.
Cancer Cell
Cell of Origin of Small Cell Lung CancerMoreover, elevated proliferation of pulmonary NE cells (PNECs)
is observed in murine lungs following acute naphthalene injury
(Stevens et al., 1997). Given these observations, we explored
whether a relationship exists between naphthalene-induced
lung injury and Trp53- and Rb1-induced SCLC. Rosa26R;
Trp53F/F;Rb1F/F mice were treated with naphthalene (or vehicle
control) and tumorigenesis was initiated (Trp53 and Rb1were in-
activated) by administration of the cell type-restricted Ad5-Cre
viruses 3–4 days following lung injury (see Figure S1A available
online). No difference, however, was observed in the median
tumor-free survival of mice infected with either Ad5-CMV-Cre
or Ad5-CGRP-Cre viruses depending upon whether or not naph-
thalene had been administered prior to switching (Figure S1B).
Thus, naphthalene-induced injury and the accompanied induc-
tion of cell proliferation, does not accelerate SCLC development
through loss of Trp53 and Rb1.
Neuroendocrine Cells Are the Predominant Cells
of Origin of SCLC
In Rosa26R;Trp53F/F;Rb1F/F mice infected with Ad5-CGRP-Cre
virus neoplastic lesions with NE differentiation were identified
by H&E staining in lungs of 25/30 mice. All tumors were located
in the central region of the lung (Figure S2A). Focal areas of intra-
epithelial neoplasia were also detected in the epithelial lining of
conducting airways (Figures 4A and 4B), strengthening the
idea that Ad5-CGRP-Cre-induced tumors originate from NE
cells. The tumors were composed of uniform small- to middle-
sized round cells that contained a course chromatin structure
and thick nuclear membrane (Figure 4C). They showed high
mitotic and apoptotic activities, with local fields of necrosis.758 Cancer Cell 19, 754–764, June 14, 2011 ª2011 Elsevier Inc.Immunohistochemical analysis of the lung tumors confirmed
their similarity to human SCLC. Many markers that stain positive
in human SCLC were also detected in our murine SCLC such as
neural cell adhesion molecule (Ncam1) (Figure 4D), synaptophy-
sin (Syn), CGRP and thyroid transcription factor-1 (TTF-1) (data
not shown). The tumors arising in these mice were highly inva-
sive, with tumor cells invading the mediastinum and thoracic
wall. Moreover, metastasis was observed in extrapulmonary
sites, such as liver (Figure 4E) and kidney, and their morpholog-
ical appearance was identical to that of the primary lung tumors.
Moreover, like their primary tumor counterpart, metastases
expressed markers of NE differentiation, such as Ncam1 (Fig-
ure 4F), Syn, and CGRP (data not shown).
In Rosa26R;Trp53F/F;Rb1F/F mice following Ad5-SPC-Cre
administration, lung tumors displaying characteristics of neuro-
endocrine differentiation were also observed, although at a lower
frequency. Interestingly however, three cases (20%) of the
Ad5-SPC-Cre cohort showed only a peripheral tumor location
(Figure S2B). This peripheral-only subset of NE lung tumors
was unique for the Ad5-SPC-Cre virus, as no such cases were
observed in the Ad5-CGRP-Cre animal cohort supporting
the notion that a peripherally located SPC-positive cell can
transform into an NE tumor following loss of Trp53 and Rb1. In
contrast, SCLC could not be induced effectively following loss
of Trp53 and Rb1 in cells expressing CC10 with only 4/30
animals showing NE tumors in the lung following infection with
Ad5-CC10-Cre virus after a very long latency. The fact that we
observed a rare switched NE cell after Ad5-CC10-Cre infection
in one of the cryosections described above might indicate that
in these few cases NE cells served as the cell of origin. The histo-
pathology of NE tumor cells after infection with Ad5-SPC-Cre
and Ad5-CC10-Cre was identical to those observed following
Ad5-CGRP-Cre infection (data not shown). PCR analysis indi-
cated that all primary NE lung tumors from Rosa26R;Trp53F/F;
Rb1F/F mice that were examined from each of the Adeno-Cre
cohorts had undergone Cre-mediated deletion of Trp53 and
Rb1 conditional alleles (Figure S2C). This was also the case in
liver metastasis isolated from individual animals (Figure S2C).
Moreover, quantitative reverse-transcription PCR (RT-PCR)
analysis confirmed the decrease in expression of Trp53 and
Rb1 in both primary lung tumors (Figure S2D) and liver metas-
tasis (Figure S2E).
Large cell sarcomatoid-like lesions were observed in the
periphery of the lungs in a small number of animals following either
Ad5-SPC-Cre or Ad5-CC10-Cre administration. The tumor cells
were large to giant in size and contained single andmultiple nuclei
(Figure S3A). Metastatic lesions in the liver were also present in
theseanimals. The tumor cells displayedahistiocytic immunophe-
notype with cells staining positive for F4/80 (Figure S3B), and
partially positive for vimentin (data not shown). Tumor cells stained
negative for cytokeratin 8 (CK8) (Figure S3C) and were also nega-
tive for pro-SPC (data not shown). The precise origin of these
tumors is unclear. However, the fact that they arose upon either
Ad5-SPC-Cre or Ad5-CC10-Cre administration suggests that
they arose from CC10/SPC positive cells and therefore could
have arisen from BASCs.
A large fraction (14/30) of Rosa26R;Trp53F/F;Rb1F/F mice in-
fected with Ad5-CC10-Cre virus, showed no neoplastic lesions
in the lung (Figure 3A and Table 2). The absence of cellular
Table 2. Occurrence of Lung Tumors in Conditional Mutant Mice
Adenovirus
Total Number
of Mice
# Mice Sacrificed with Described
Pathology/# of Mice Analyzed
Histopathology of
Lung Lesions
Lesion Latency
(days)
Ad5-CMV-Cre 47a 4/47 No lesions 297–517
3/47 NE hyperplasia 196–286
40/47 NE tumor 201–339
Ad5-CGRP-Cre 5b 3/5 Simple hyperplasia (NE cells) 182–275
30a 1/5 NE tumor 238
4/30 No lesions 224–287
1/30 Spindle cell NE tumor 206
25/30 NE tumor 255–464
Ad5-SPC-Cre 2b 2/2 No lesions 252
33a 9/33 No lesions 386–684
15/33 NE lung tumor 319–613
4/33 Sarcoma 529–649
1/33 Papillary carcinoma 407
1/33 Adenocarcinoma 642
3/33 Other 562–573
Ad5-CC10-Cre 2b 1/2 No lesion 280
30a 1/2 Simple hyperplasia (Clara cells) 280
14/30 No lesions 236–684
3/30 NE tumor 389–640
1/30 NE tumor and alveolar hyperplasia 601
7/30 Bronchiolar hyperplasia 333–684
2/30 Alveolar hyperplasia 333–601
2/30 Sarcoma 663–679
1/30 Other 204
The total number of mice analyzed for each genotype and the occurrence of NE tumors and other lung lesions at different time points is presented.
aMice sacrificed when symptoms occurred or died of old age. See also Figure S3 for additional histopathology.
bMice arbitrarily sacrificed.
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ated recombination, as b-galactosidase positive cells, a read-
out of Trp53 and Rb1 recombination, were readily detected in
Rosa26R;Trp53F/F;Rb1F/F animals 410–684 days following Ad5-
CC10-Cre virus infection (data not shown). Interestingly, atypical
hyperplasia of bronchiolar epithelial lining cells was observed in
7/30 (23%) mice 383–684 days following Ad5-CC10-Cre injec-
tion. The cells in these lesions were characterized by an
increased nuclear to cytoplasm ratio and hyperchromatic nuclei
(Figure S3D). Moreover, the lesions showed a high proliferation
index, as determined by Ki67 immunostaining (Figure S3E). In
contrast to the simple hyperplastic lesions, the atypical hyper-
plasic cells would appear to be solely of Clara cell origin, as
they stained positive for CK8, CC10, but were negative for Syn
(Figure S3F, data not shown).
Involvement of SPC-Positive Cells
in Trp53- and Rb1-Induced SCLC
Given the fact that loss of Trp53 and Rb1 in SPC-positive cells
gives rise to SCLC, although at a much lower efficiency, we
were interested in assessing the expression level of pro-SPC
in primary lung tumors and liver metastasis isolated from
Rosa26;Trp53F/F;Rb1F/F animals. Consistent with the NE fea-
tures of SCLC, the NE cell marker CGRP (Calca) was highly ex-pressed in all primary NE lung tumor samples isolated
from mice infected with different cell type-restricted Ad5-Cre
viruses. In contrast, the Clara cell marker, CC10 (Scgb1a1)
was not detected in the vast majority of NE tumors examined
(Figure 5A). Interestingly, the alveolar cell marker, SPC (Sftpc)
was detectable in a high number of primary NE tumor samples,
although at a much reduced level to that observed in normal
lung tissue (Figure 5A). As we cannot exclude the possible
contamination of normal lung tissues in our tumor preparations,
we made use of a series of clonal cell lines derived from mouse
SCLC. A subset of cell lines, termed NE cells, grow as suspend-
ing cell aggregates and express markers of NE differentiation.
The remaining subset of cell lines grow as an attached mono-
layer composed of larger cells with visible cytoplasms and based
on these phenotypic observations were termed non-NE cells
(Calbo et al., 2005, 2011). Consistent with previous observations,
high expression ofCalcawas detected in NE clonal cell lines, but
absent in non-NE cell lines. The expression of Sftpc was also
detected, although at extremely low levels, in clonal NE cell lines,
but absent in non-NE cells (Figure 5B). Expression of Scgb1a1
was below detectable levels in all cell lines examined (data not
shown). Although, this observation would point to the possibility
that NE cells can be switched, although relatively inefficient, by
Ad5-SPC-Cre viruses, our inability to find even a single switchedCancer Cell 19, 754–764, June 14, 2011 ª2011 Elsevier Inc. 759
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Figure 4. NE Cells Are Target Cells for Transformation in Trp53- and
Rb1-Induced SCLC
Representative lesions are shown from Rosa26R;Trp53F/F;Rb1F/F mice 238–
464 days following Ad5-CGRP-Cre administration.
(A and B) H&E-stained section of an intraepithelial neoplasia of NE cells.
(C) H&E-stained section of an NE lung tumor showing large mass formation
and massive infiltration into the surroundings.
(D) Immunostaining with antisera raised against the NE cell marker Ncam1.
(E) H&E-stained section of metastasis to the liver.
(F) Immunostaining of liver metastasis with antisera raised against Ncam1.
Scale bars: (A), (C), and (D) equal 100 mm; (B) equal 20 mm; (E) and (F) equal
50 mm. See Figure S2 for images related to tumor location, Trp53 and Rb1
recombination efficiencies and expression analysis.
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explanation.DISCUSSION
In this study, we have directly addressed questions related to the
cell-of-origin of lung cancer through the generation of cell type-
restricted adenoviruses, which have the ability to direct Cre
recombinase expression to a defined, yet small number of adult
lung cells in vivo. This strategy is advantageous as it allows the
induction of sporadic mutations in a small number of cells in their
normal tissue microenvironment, and thus more closely mimics
the way in which tumors develop in man. Transgenic models di-
recting inducible expression of Cre recombinase to the proximal
and distal airways using the 2.3 kb rat Scgb1a1 promoter and
the 3.7 kb human SFTPC promoter, respectively, have been
described previously (Perl et al., 2002a; Stripp et al., 1992).760 Cancer Cell 19, 754–764, June 14, 2011 ª2011 Elsevier Inc.However, in these systems problems related to misexpression
of Cre recombinase in cells other than the cells of interest were
noted (for review, see Perl et al., 2009). With our adenoviral
vectors we obtained a very high level of cell type specificity as
based on Cre reporter assays performed in Rosa26R-LacZ and
mT/mG reporter mice (Figures 1 and 2 and Table 1).
Although our Ad5-CGRP-Cre virus targets an extremely small
number of cells, induced loss of Trp53 andRb1 in these rare cells
gives rise to a very high incidence of lung tumors that display NE
differentiation and SCLC morphology (Figure 4). This tumor inci-
dence is similar to that achieved with Ad5-CMV-Cre virus, which
infects over 100-fold more cells in the lung. As seen in humans,
Ad5-CGRP-Cre-induced tumors were centrally located and
aggressive in nature, exhibiting a marked capacity to metasta-
size to liver. Moreover, mouse SCLC tumors express numerous
cellular markers that are also used to mark human SCLC tumors,
such as high levels of TTF-1. Taken together, these tumors show
a striking similarity to human SCLC. Thus, our study supports the
notion that Ad5-CGRP-Cre infects the predominant cell of origin
of SCLC. Our findings therefore provide strong in vivo evidence
that NE cells serve as the prevalent target cell of origin of SCLC
(Figure 6).
Interestingly, directed expression of H-ras to pulmonary NE
cells using a CGRP promoter-driven transgenic construct, re-
sulted in the formation of only bronchial adenocarcinomas
(Sunday et al., 1999). These observations, together with our
own, indicate that different genetic lesions can drive the same
target cells down a divergent differentiation path. It suggests
that an active Ras pathway in these cells does not permit the
cells to retain their neuroendocrine features, while loss of both
Rb1 and Trp53 promotes the neoplastic transformation of NE
cells. Our recent studies in which introduction of an activated
Ras can convert NE SCLC cells into cells that completely change
their phenotype and now resemble more closely NSCLC adeno-
carcinomas supports this and argues that mutant Ras can act
dominantly in commanding the lung cancer phenotype (Calbo
et al., 2011).
In the adult mouse lung, NEBs are foundwithin niches contain-
ing Clara cells and variant Clara cells, some of which cover the
luminal surface of the NEB (De Proost et al., 2008). From these
observations, a relationship between NE and Clara cells has
long thought to exist and thus, Clara cells have also been spec-
ulated to serve as cells of origin of SCLC. Our data argue against
this possibility. From our mT/mG reporter animal analysis, we
observed upon screening through a series of thick cryosections
colocalization between one Ad5-CC10-Cre-switched cell and
a Syn+ cell, present within a NEB. This rare aberrant Cre expres-
sion in NE cells could account for the few cases of SCLC
observed following administration of Ad5-CC10-Cre. More
frequently, however we observed switching of Clara cells adja-
cent to NEBs. Alternatively, the rare occurrence of SCLC after
administration of Ad5-CC10-Cre could result from the uptake
of Cre protein in NE cells from an adjacent highly Cre-expressing
Clara cell.
Although NE cells appear the predominant cancer-initiating
population in SCLC, our data also support the presence of an
SPC-positive progenitor cell population that can give rise to
SCLC following loss of Trp53 and Rb1, albeit with a lower pene-
trance (Figure 6). We do not believe that our Ad5-SPC-Cre virus
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Figure 5. Low Expression of SPC in Primary
SCLC Tumors and Mouse SCLC Clonal Cell
Lines
(A) The expression ofCGRP (black bars), Scgb1a1
(white bars), and SPC (gray bars) transcripts rela-
tive to Hprt was determined by quantative PCR
analysis of RNA derived from primary lung tumors
from Rosa26R;Trp53F/F;Rb1F/F animals infected
with Ad5-CMV-Cre, Ad5-CGRP-Cre, Ad5-SPC-
Cre, and Ad5-CC10-Cre viruses. Two tumor
samples are shown for each virus. Values are
represented relative to levels detected in RNA
extracted from normal lung. Data shown represent
mean ± SD.
(B) The expression of CGRP (black bars), SPC
(gray bars), and Scgb1a1 (white bars) relative to
Hprt was determined by quantative PCR analysis
of RNA derived from mouse SCLC clonal cell
lines: neuroendocrine (NE) cell lines and non-
neuroendocrine (non-NE) cell lines. Three cell lines
are shown for each.
Values are represented relative to levels detected
in RNA extracted from normal lung. Data shown
represent mean ± SD.
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reporter assays. In agreement with previous studies our findings
in reporter animals indicate that the mouse SPC promoter
exhibits a highdegreeof cell type specificity toAT2cells (Figure 1)
(Glasser et al., 1990, 2005). This observation implies that there
might be a population of SPC-positive cells that, upon loss of
Trp53 and Rb1, acquire the capacity to give rise to SCLC. A
cell type that immediately comes to mind is the BASC. BASCs
have been proposed to be the cell of origin of K-ras-induced
NSCLC (Kim et al., 2005). This rare cell type located at the
BADJ expresses both CCSP and SPC, and thus would be tar-
geted by both our Ad5-CC10-Cre and Ad5-SPC-Cre viruses. If
BASC cells acted as cancer-initiating cells for SCLC, however,
one would expect that both Ad5-CC10-Cre and Ad5-SPC-Cre
viruses are similarly effective in inducing SCLC. Contrary to this
assumption, only a very small number of Rosa26R;Trp53F/F;
Rb1F/F animals exhibited SCLC following Ad5-CC10-Cre virus
inoculation, while a pronounced fraction of animals exhibited
SCLC following Ad5-SPC-Cre virus administration. Indeed, it is
feasible, that recombination efficiencies may vary among the
adenoviral vectors due the to activity of Cre-driven promoters
within a distinct cellular compartment. However, given the robust
switching we observe with Ad5-CC10-Cre and to a lesser extent
Ad5-SPC-Cre of theRosa26R-LacZ reporter which switches less
efficient than either the Trp53 and Rb1 conditional alleles (Vooijs
et al., 2001), it is very unlikely that BASCs are the cell of origin of
SCLC in Ad5-SPC-Cre-infected animals.
It is more likely that other cell types that express SPC have the
capacity to give rise to SCLC. In this respect it is noteworthy thatCancer Cell 19, 754–7a fraction of the SCLC cell lines also
express SPC (Figure 5), suggesting that
SPC is expressed in the lineage of the
cell of origin of SCLC. This points to the
existence of an early progenitor thatexpresses low levels of SPC and has the capacity to differentiate
along the neuroendocrine lineage. This could be a common
progenitor residing in the lung or a committed progenitor that
trans-differentiates under pressure of the concomitant loss of
Trp53 and Rb1. In support of the former, it is interesting to
note that there is evidence for a multipotent progenitor cell in
the immature and developing lung (Rawlins et al., 2009a; Wuen-
schell et al., 1996). However, the existence of a corresponding
multipotent progenitor population in the adult lung remains illu-
sive and is currently the focus of much investigation.
We should also not underestimate the influence specific
genetic mutations may have on the target cell. Rb1 is a critical
controller of NE differentiation and its loss could be amechanism
by which a progenitor-like AT2 cell could differentiate toward
a more NE cell-like state. The observed peripheral location of
SCLC in a distinct subset of the Ad5-SPC-Cre but not the Ad5-
CGRP-Cre induced tumors supports this notion. In line with
this hypothesis it has been shown that Rb1 can regulate cell
fate choice and lineage commitment both in epithelial (Wikenhe-
iser-Brokamp, 2004) andmesenchymal cells (Calo et al., 2010). It
should be noted that it is unlikely that every SPC-positive cell has
the capacity to develop a NE tumor following loss of Trp53 and
Rb1. Instead, the susceptibility of a subset of SPC-positive cells
to tumor development might be a consequence of intrinsic capa-
bilities inherent to progenitor cells. In this regard, it is interesting
to note that activation ofK-rasV12 in lung causes only a small frac-
tion of the cells to give rise to hyperplastic growth arguing that
specific cell autonomous features or microenvironmental condi-
tions are required to support tumor initiation (Guerra et al., 2003).64, June 14, 2011 ª2011 Elsevier Inc. 761
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Figure 6. Hypothetical Schematic of Trp53- and Rb1-Induced SCLC
Loss of Trp53 and Rb1was restricted to specific cell types in the adult lung by
cell type-restricted Ad5-Cre viruses. Loss of Trp53 and Rb1 in CGRP-positive
NE cells (red) efficiently gave rise to NE lung tumors, indicating that NE cells are
the predominant cells of origin for SCLC. SCLC was detected in a substantial
number of Rosa26R;Trp53F/F;Rb1F/F animals following Ad5-SPC-Cre infec-
tion. It remains unclear whether this is due to loss in a differentiated AT2 cell
(yellow), or whether loss occurs in a more rare SPC-expressing progenitor cell
type (orange) that has the ability to differentiate along the NE cell lineage.
SCLC could not be effectively induced following directed loss of Trp53 and
Rb1 to CC10-positive Clara cells (white). Ciliated cells, (green), were not tar-
geted by the cell type-restricted Ad5-Cre viruses.
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predominant cell of origin of SCLC. Targeting Trp53 and Rb1
loss to any other cell results in a much lower or even negligible
incidence. These findings are also relevant for the treatment of
SCLC that is notoriously difficult to control as it invariably
relapses after an initial response to chemotherapy (Jackman
and Johnson, 2005). The notion that NE cells are the predomi-
nant cells of origin of SCLC implies that we should concentrate
on this specific cell type in the design of therapies and be less
concerned about an elusive cancer-initiating cell with different
characteristics. Very little is still known about the lineage rela-
tionship of NE cells to other cell types in the lung. Although NE
cells are also found in microenvironments that have been shown
to maintain stem cell populations, it would appear that NE cells
do not behave as lung stem cells. Rather they exhibit properties
of uni-potent progenitor cells (Reynolds et al., 2000a, 2000b).
If this is indeed the case, then designing strategies to specifically
eradicate rapidly dividing NE cells may have acceptable toxic
side effects. At the same time, we should keep an eye on the
propensity of these neuroendocrine tumors to undergo rather
dramatic changes upon the activation of other signaling path-
ways as is evident from activation of the Ras pathway in these
cells. This might be one of the routes of SCLC to become refrac-
tory to treatment by Cisplatin.762 Cancer Cell 19, 754–764, June 14, 2011 ª2011 Elsevier Inc.In conclusion, our strategy to manipulate specific adult lung
cell populations in a controlled manner by cell type-restricted
somatic gene transfer vectors can help to answer the question
of whether distinct lung pathologies have a unique cell of origin
and whether this cell of origin is a determining factor in the
drug resistance profile of the various tumor subtypes.
EXPERIMENTAL PROCEDURES
A detailed description of the materials andmethods utilized in this work can be
found in the available online Supplemental Experimental Procedures.
Mouse Strains
All experiments involving animals comply with local and international regulations
and ethical guidelines, and have been authorized by our local experimental
animal committee at The Netherlands Cancer Institute (DEC-NKI). The mouse
small cell lungcancermodelbasedonconditionalTrp53F2-10/F2-10 andRb1F19/F19
animals was previously described (Meuwissen et al., 2003). These animals were
crossed with Rosa26R-LacZ reporter animals (Soriano, 1999). The mT/mG
double fluorescent reporter animal (Muzumdar et al., 2007)was genotyped using
the following primers: 50- CTCTGCTGCCTCCTGGCTTCT-30, 50- CGAGGCG
GATCACAAGCAATA-30, and 50- TCAATGGGCGGGGGTCGTT-30.
Generation of Recombinant Cell-Specific Adeno-Cre Viruses
An attB-flanked PCR linker, containing multiple restriction enzyme cloning
sites (linker #7 50-AAA AAG CAG GCT CAG ATC TAG CGA AGC TTG CGC
CAT CCC TGG AATTCGCCCCGCTCGAGCATAACCCAGCTTTCT-30, linker
#9 50-AAAAAGCAGGCTCGGTACCAGCAGATCTAGCGAAGCTTGCGCCATC
CCTGGAATTCGCCC CGCTCGAGCATAACCCAGCTTTCT-30 ), was amplified
and subsequently recombined into the pDONR221 vector (Invitrogen). For
cell type-specific expression of Cre recombinase, a fragment containing the
Cre open reading frame with an N-terminal synthetic intron and C-terminal
polyadenylation signal was isolated from pOG231 (O’Gorman et al., 1997).
This fragment was then inserted either behind the 2.1 kb mouse CC10
promoter (Linnoila et al., 2000) in pDONR221 or behind the 4.8 kb mouse
surfactant protein C promoter (Glasser et al., 2005) in pDONR221. Cloned
pDONR221 constructs were then recombined into promoter-less pAd-PL
DEST vectors (Invitrogen) by Gateway LR recombination, to generate Ad5-
CC10-Cre and Ad5-SPC-Cre adenoviral constructs. The 2.0 kb rat calci-
tonin/CGRP promoter (Johnston et al., 1998) was cloned upstream of the
Cre open reading frame as described. High titer adenoviruses were amplified
and purified for use in vivo by the University of Iowa Gene Transfer Vector
Core, supported in part by the NIH and the Roy J. Carver Foundation, for viral
vector preparation.
Intratracheal Adeno-Cre Virus Administration
Seven-week-old mice were treated with cyclosporine A (Novartis) orally in the
drinking water, 1 week prior to adenovirus administration and 2–3 weeks
following adenovirus infection. Mice were intratracheally intubated with 20 ml
of purified Adeno-Cre viruses.
Immunohistochemistry and X-Gal Staining
For histological analysis, lungs were inflated with ethanol-acetic acid-formalin
(EAF) and fixed for 24 hr in EAF. Fixed tissues were subsequently dehydrated,
embedded in paraffin and sections (2 mm) prepared and stained by hematox-
ylin and eosin (H&E). We carried out immunohistochemistry for: anti-Ncam1
(rabbit polyclonal, Millipore), anti-synaptophysin (rabbit polyclonal, DAKO),
anti-pro-SPC (rabbit polyclonal, Chemicon), anti-CCSP (goat polyclonal),
Ki67 (rat monoclonal, DAKO), Cytokeratin 8 (rat monoclonal, Developmental
Studies Hybridoma Bank). Streptavidin-peroxidase (DAKO) or PowerVision
Poly-HRP (Leica Micosystems), were used for visualization and diaminobenzi-
dine as a chromagen (DAKO). To detect b-galactosidase activity, whole lungs
were stained in X-gal staining solution as previously described (Sum et al.,
2005), and then processed for paraffin embedding. Three sections were
prepared, 50 mm apart, stained with nuclear fast red and examined by light
microscopy.
Cancer Cell
Cell of Origin of Small Cell Lung CancerImmunofluorescence Microscopy
For immunofluorescencemicroscopy, lungswere inflatedwith 4%paraformal-
dehyde (PFA) and fixed 4 hr in 4% PFA. Lungs were washed in PBS, sucrose-
protected and mounted in cryomatrix. Immunocytochemical staining was
performed using: anti-CCSP (goat polyclonal), anti-pro-SPC (rabbit poly-
clonal, Chemicon), anti-synaptophysin (Syn, Guinea-pig polyclonal, Synaptic
Systems), and Calcitonin gene-related peptide (CGRP, rabbit polyclonal,
Sigma). Detailed imageswere obtained using amicrolens-enhanced dual spin-
ning disk confocal microscope (UltraVIEW, PerkinElmer).
Gene Expression Analysis
Total RNA was isolated from primary mouse lung tumors using TRIzol reagent
(Life Technologies) according to the manufacturer’s instructions, and then
treated with DNA-free Kit (Ambion). cDNA was prepared using the 1st Strand
cDNA Synthesis Kit for RT-PCR (AMV) (Roche), according to the manufac-
turer’s specifications. For real-time PCR, cDNA was subjected to 40 cycles
of amplification using either the Applied Biosystems TaqMan gene expression
assays or the Applied Biosystems SYBR Green expression assay, as per the
manufacturer’s instructions.
Mouse SCLC Cell Lines
Clonal cell lines derived from SCLC tumors excised from compound Trp53F/F;
Rb1F/F animals has been previously described (Calbo et al., 2005, 2011). Cells
are maintained in modified HITES medium DMEM/F12 (1:1) (GIBCO) supple-
mented with Glutamax, 4 mg/ml Hydrocortisone (Sigma), 5 ng/ml murine
EGF (Invitrogen), Insulin-Transferrin-Selenium mix/solution (GIBCO) and
10% Fetal Bovine Serum (Greiner Bio one). Cells are cultured at 37C in
a humidified atmosphere of 95% air and 5% CO2.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at doi:10.1016/j.
ccr.2011.04.019.
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